Electrocore ECOR 深 沪
已收盘 10-10 16:00:00 美东时间
5.00
-0.260
-4.94%
华盛通- 最 高5.38
- 今 开5.27
- 成交量 4.40万股
- 最 低 4.9701
- 昨 收 5.26
- 总市值 3791.70万
- 52周最高 19.49
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 4.16
- 委 比 -22.78%
- 总股本 758.34万
- 历史最高 303.75
- 量 比 0.77
- 振 幅 7.79%
- 历史最低 2.925
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Electrocore Finalizes Stock Sale to Settle Legal Fees
Electrocore ( ($ECOR) ) has issued an announcement. On September 30, 2025, Elec...
10-04 04:58
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
ElectroCore's gammaCore device shows promise in reducing symptoms of mild traumatic brain injury (mTBI), according to a study published in *Frontiers in Neurology*. The research involving 102 patients found significant improvements in 16 out of 22 symptom categories, with 34% of participants reporting meaningful relief in at least half their symptoms. Notably, benefits were observed regardless of the time since injury, and no adverse device-relat...
09-30 12:00
electroCore Announces Its GammaCore Sapphire Non-Invasive Vagus Nerve Stimulation Device Has Been Included In Long-Term Reimbursement Policy By Belgium's National Institute For Health And Disability Insurance
electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV / INAMI) in Belgium.
09-29 20:12
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
electroCore's gammaCore Sapphire (nVNS) has been included in Belgium's long-term reimbursement policy by RIZIV/INAMI, effective October 1, 2025, covering cluster headache treatment. The decision, supported by clinical evidence of efficacy and cost-effectiveness, improves access for Belgian patients. Silvert Medical, electroCore's partner, played a key role in securing this reimbursement.
09-29 12:00
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
electroCore's Truvaga™ Plus device, a handheld vagus nerve stimulator, has been awarded "Best Relaxation Gadget" in Esquire’s 2025 Sleep Awards. The device, recognized for its ability to reduce stress and promote sleep in just two minutes, was selected after rigorous testing. As a leader in bioelectronic medicine, electroCore emphasizes its commitment to enhancing health through innovative, non-invasive solutions. The Truvaga Plus also offers a r...
09-22 12:00
Ecora Resources Completes $20M Royalty Sale of Dugbe Gold Project
Ecora Resources ( ($GB:ECOR) ) has shared an announcement. Ecora Resources PLC ...
09-11 16:57
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Andy Brown has been appointed as the VP, Corporate Controller of electroCore, Inc., effective September 9, 2025. The Company granted him 10,000 RSUs, vesting equally over three years, contingent on continued employment.
09-10 20:05
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
ElectroCore, Inc. announced the departure of Peter Cuneo from its Board of Directors, with Thomas J. Errico, MD, elected as the new Chairman. Cuneo will continue as a strategic advisor. CEO Dan Goldberger praised Cuneo's contributions and welcomed Errico, highlighting his role in advocating for shareholders and his leadership as Chairman of the Nominating and Governance Committee. ElectroCore specializes in bioelectronic technologies, offering no...
09-05 12:00
Ecora Resources Gains from Successful Cobalt Test at Voisey’s Bay
An announcement from Ecora Resources ( ($GB:ECOR) ) is now available. Ecora Res...
09-04 22:42
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
electroCore, Inc. partners with former NFL star Greg Buttle to promote its new Truvaga Plus device, a handheld vagus nerve stimulator designed to improve sleep, focus, and relaxation. Buttle, known for his sports career and commitment to wellness, will help raise awareness of the drug-free technology that provides quick, effective results in just two minutes. Truvaga Plus, supported by over 20 years of research, is aimed at enhancing overall well...
09-04 12:00
